The use of electromagnetic radiation and related technologies to obtain images of internal structures of the body for accurate diagnosis is known as medical or diagnostic imaging. A diagnostic imaging marker is a biomarker or a biologic feature that is detectable in an image. This image is relevant to the diagnosis of a patient for a certain disease.
Diagnostic imaging includes certain radiation technique; X-Ray imaging, endoscopy, magnetic resonance imaging, computed tomography scan, ultrasound etc. The diagnostic imaging markers are either placed in or around the part of the body that needs to be screened. These markers help in target localization of the tumor or the diseased organ. Digital imaging markers aid in knowing the exact position of the tumor, further depicting the severity, shape and size of the diseased organ/ tumor.
Diagnostic imaging markers are highly used for cancer diagnosis. For instance, for lung cancer, these diagnostic imaging markers can be used for the assessment the calcification, cavitation, speculation, rate of growth, location within the lung, and rate of metabolism of the tumor.
Increasing incidence of various forms of cancer, like lung, skin, abdomen, kidney, prostate, breast, etc., and other chronic diseases that require diagnostic imaging for better diagnosis of the disease is expected to be a major factor driving the diagnostic imaging markers market during the forecast period. Growing FDA approvals for these markers are contributing to better and novel technologies for better diagnosis of these diseases.
This is also expected to boost the diagnostic imaging markers market. Technological advancements in the imaging modalities and growing preference for minimally invasive procedures for diagnosis might also drive the market growth for diagnostic imaging markers during the forecast period. However, extremely high costs associated with diagnostic imaging systems, unfavourable healthcare reforms and stand-alone systems limitations might hinder the market growth for diagnostic imaging markers market during the forecast period.
Global Diagnostic Imaging Markers market has witnessed growth due to expanding demand for diagnostic services. According to the World Health Organization, certain surgical interventions can be avoided if diagnostic imaging is available, like ultrasound and X-ray procedures. There is a consistent increment in skin related disorders leading to cancer growths.
Increase in oncology diseases and related ailments is boosting a high demand for Diagnostic Imaging Markers. Diagnostic Imaging Markers for dermatology services is also being practiced rigorously. Growing incidences of skin disorders and related ailments is also responsible for boosting the market growth for diagnostic imaging markers. Government support and funding is also resulting in increase in number of cancer and other related diagnostic centers.
Geography wise, Diagnostic Imaging Markers market is divided into eight regions viz. North-America, Asia- Pacific excluding China & Japan, China, Japan, Western Europe, Eastern Europe, Latin America and Middle-East & Africa. North America’s Diagnostic Imaging Markers market is expanding because of increase in FDA approved markers and high availability of diagnostic systems in diagnostic centers. The market is expected to remain dominant during the period of forecast due to increasing government funding and increase in healthcare expenditure.
North America’s Diagnostic Imaging Markers market is expected to grow the fastest due to high number of cancer cases and growing geriatric population requiring diagnostic treatment and services. Asia-Pacific Diagnostic Imaging Markers market is anticipated to grow at a decent rate due to growing awareness on Diagnostic Imaging Markers, growing medical tourism and development of healthcare facilities in the region.
Some of the market participants in the Global Diagnostic Imaging Markers market identified across the value chain include: PDC Healthcare, IBA, Hologic Inc, Magic X-Ray Markers, Innovative Oncology Solutions, Boston Scientific, IBA, Best Medical International, Inc., IZI Medical Products, Carbon Medical Technologies, CIVCO, alphaXRT, Nanovi A/S and Stellar Medical.
The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
On the basis of Application, Diagnostic Imaging Markers Market can be segmented as:
On the basis of end users, Diagnostic Imaging Markers Market can be segmented as:
On the basis of geography, Diagnostic Imaging Markers Market can be segmented as:
Explore Similar Insights
Diagnostic Imaging Markers Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
